MétaCan
Menu
Back to cohort
Record W2090166561 · doi:10.1158/1538-7445.am2012-805

Abstract 805: The role of aldo-keto reductases and estrogen signalling in acquired anthracycline resistance

2012· article· en· W2090166561 on OpenAlexaff
Simon Chewchuk, Amadeo M. Parissenti

Bibliographic record

VenueCancer Research · 2012
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicAldose Reductase and Taurine
Canadian institutionsLaurentian University
Fundersnot available
KeywordsAnthracyclineBreast cancerDoxorubicinCancer researchEstrogen receptorEstrogenCyclin D1BiologyEpirubicinCancerInternal medicineChemotherapyEndocrinologyMedicineCell cycle

Abstract

fetched live from OpenAlex

Abstract Breast cancer is the second leading cause of death from cancer in North American women. The disease can be difficult to treat by adjuvant or neoadjuvant chemotherapy because of intrinsic or acquired resistance to chemotherapy agents. To better understand the mechanisms for acquired resistance to the anthracycline class of chemotherapy agents in breast cancer, a series of MCF-7 breast tumour cell lines have been developed that exhibit progressive resistance to epirubicin (MCF-7EPI cells) or to doxorubicin (MCF-7DOX2 cells). Following mRNA microarray analysis, several genes were identified whose expression was associated with the acquisition of anthracycline resistance. Among these were several Aldo-keto Reductases (AKRs) responsible for estrogen synthesis from estrone and anthracycline detoxification to 13-hydroxymetabolites. AKR 1C3 showed more than a 10-fold increase in expression in anthracycline-resistant breast tumour cells. We hypothesized that the over-expression of AKR 1C3 would lead to both increased drug detoxification and an increase in estrogen synthesis. This would result in increased tumour cell survival and growth in the presence of anthracyclines. Recently, we observed that estrogen levels were, in fact, increased as cells became anthracycline-resistant. In contrast, the expression of estrogen receptor ≤ (ESR1) was reduced by 2- to 5-fold at the gene level and 2- to 20- fold at the protein level, with a concomitant reduction in the estrogen-dependent expression of Bcl-2 and Cyclin D1. Diminished Bcl-2 and cyclin D1 expression would be expected to reduce the growth rate of the cells, a hypothesis we have confirmed in cell culture experiments. Taken together, our findings suggest that selection for anthracycline resistance in breast tumour cells results in alterations in AKR expression, resulting in enhanced detoxification of doxorubicin, the promotion of estrogen biosynthesis, and the reduced estrogen-dependent expression of Bcl-2 and cyclin D1. The reduced expression of Bcl-2 and cyclin D1 blunts the growth rate of anthracycline-resistant cells, which would further increase the ability of these cells to survive in the presence of anthracyclines. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 805. doi:1538-7445.AM2012-805

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.070
Threshold uncertainty score0.286

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.039
GPT teacher head0.371
Teacher spread0.333 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2012
Admission routes1
Has abstractyes

Explore more

Same venueCancer ResearchSame topicAldose Reductase and TaurineFrench-language works237,207